Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory SignalsArticle Published on 2021-09-272022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] alanine aminotransferase Analysis assessment Causality Characteristics clinical manifestations Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 daily dose defined demonstrated drug drug induced liver injury (DILI) Drug-induced liver injury drugs Hepatitis hepatocellular hepatotoxic highest hospital hospitalised Hydroxychloroquine immune mechanism incidence incidence rate Laboratory limit Liver damage lymphocyte transformation lymphocyte transformation test (LTT) marker mechanism Mild Patient patients performed pharmacovigilance positive Program Remdesivir severity signal Spain subsequent recovery subset Tocilizumab treated university updated Roussel Uclaf Causality Assessment Method (RUCAM) was performed with COVID-19 [DOI] 10.3390/jcm10194432 PMC 바로가기 [Article Type] Article
Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting databaseArticle Published on 2021-09-042023-06-16 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, [키워드] Bell's palsy COVID-19 facial nerve palsy mRNA vaccine pharmacovigilance VAERS [DOI] 10.1016/j.ijid.2021.08.071 PMC 바로가기 [Article Type] Article
Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medicationResearch article Published on 2021-09-012022-10-05 Journal: Annales pharmaceutiques françaises [Category] 치료제, [키워드] ADR ADRS Adverse drug reaction affected analyzed ATC Characteristics children consequence COVID-19 COVID-19 outbreak Descriptive statistics disorders drugs effective First wave French Impact information mandatory material median age medication nervous system Non-COVID-19 objective pandemic Patient pharmacovigilance proportion recorded reported Result Self-medication were used [DOI] 10.1016/j.pharma.2021.02.003 [Article Type] Research article
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report렘데시비르 또는 하이드록시클로로퀸으로 치료받은 COVID-19 환자의 약물 부작용을 평가하기 위한 전향적 관찰 연구: 예비 보고서Observational Study Published on 2021-09-012022-09-11 Journal: European Journal of Hospital Pharmacy [Category] 임상, 치료제, [키워드] activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 ADR ADRS Adverse drug reaction Adverse drug reactions adverse effect Adverse reactions authorisation baseline characteristics carried Causality clinical medicine Cohort cohorts coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 cumulative drug monitoring drug-related side effects and adverse reactions Efficacy EMA European Medicines Agency evaluate greater HCQ Health authority hospital hospitalised Hydroxychloroquine implementation incidence Local Observational cohort study outbreak participant Patient patients patients with COVID-19 pharmacovigilance pharmacy service preliminary report pressure public health real-world data regimen REM Remdesivir reported safety profile SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Side effect Side effects study period Suspected System Therapeutic strategies treated Treatment treatment of COVID-19 [DOI] 10.1136/ejhpharm-2020-002613 PMC 바로가기 [Article Type] Observational Study
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO databaseCOVID-19의 Tocilizumab: WHO 데이터베이스에 보고된 약물 부작용 연구Article Published on 2021-09-012022-09-12 Journal: Expert opinion on drug safety [Category] 진단, [키워드] abnormality ADE ADEs Administered Adverse Drug Event Affect Americas analyzed clinical variables Complication Coronavirus disease 2019 COVID-19 COVID-19 patient database European event hematological Hepatitis higher odd highest humanized monoclonal antibody infections Inflammatory cytokine interleukin-6 intravenously lung majority male monoclonal monoclonal antibody organ pharmacovigilance poisoning poor prognosis receptors recipients Region reported Research design severity significantly lower the WHO Tocilizumab treat WHO World Health Organization [DOI] 10.1080/14740338.2021.1946513 PMC 바로가기 [Article Type] Article
Auto-immune hepatitis following COVID vaccinationCase Reports Published on 2021-09-012023-06-13 Journal: Journal of autoimmunity [Category] B형 간염, SARS, [키워드] adverse effects Auto-immune hepatitis COVID-19 Covishield molecular mimicry outcomes pharmacovigilance SARS-CoV-2 Treatment vaccination [DOI] 10.1016/j.jaut.2021.102688 [Article Type] Case Reports
How the Global COVID-19 Pandemic Brought Drug and Vaccine Development into the Public Mainstream글로벌 COVID-19 팬데믹이 어떻게 약물 및 백신 개발을 대중의 주류로 끌어들였습니까?Review Published on 2021-09-012022-09-11 Journal: Pharmaceutical medicine [Category] 신약개발, [키워드] approved Clinical studies COVID-19 development drug Drug development drugs Effect effective vaccine Effective vaccines Effects effort Evolution health system health systems implementation include individual Infection mainstream pandemic Patient pharmaceutical pharmacovigilance populations Prevent product Public Regulatory SARS-CoV-2 virus the SARS-CoV-2 virus treat Vaccine [DOI] 10.1007/s40290-021-00402-y PMC 바로가기 [Article Type] Review
Skin Adverse Reactions to Novel Messenger RNA Coronavirus Vaccination: A Case SeriesBrief Report Published on 2021-08-272022-11-01 Journal: Diseases [Category] COVID-19, [키워드] Adverse Adverse reaction Adverse reactions age anaphylaxis authority characterized contribute coronavirus vaccine corticosteroid treatment COVID-19 COVID-19 vaccination delayed skin reactions dose edema effective erythematous facial FIVE Guidance Health care worker high risk individual injection Italian Italy lesions messenger Messenger RNA Mild novel novel messenger RNA coronavirus vaccine Nurses observation period occur occurred Patient patients pharmacovigilance physician preventive measure pruritus Rash reaction reduce mortality reported RNA Safe Sardinia second dose Sery skin skin adverse reactions Spontaneous Spread Treatment vaccination Vaccine were excluded widespread women [DOI] 10.3390/diseases9030058 PMC 바로가기 [Article Type] Brief Report
Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up systemArticle Published on 2021-08-182023-06-23 Journal: Human vaccines & immunotherapeutics [Category] 신종인플루엔자, [키워드] adverse events immunization influenza vaccines pharmacovigilance post-marketing safety surveillance risk management plan Safety Seasonal influenza vaccination [DOI] 10.1080/21645515.2021.1935170 PMC 바로가기
Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador2019년 엘살바도르에서 오가나 백신의 잠재적 안전 신호를 평가하기 위한 보고된 약물 부작용 사건의 불균형 분석Article Published on 2021-08-092024-08-18 Journal: Vaccine [Category] 백일해, 파상풍, [키워드] Adverse events following immunization El Salvador febrile seizure pentavalent vaccine pharmacovigilance vaccine safety [DOI] 10.1016/j.vaccine.2021.07.010